{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.666.5.896",
  "meta" : {
    "versionId" : "20",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Lantana EH Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-03"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2016-03-31"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.896",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.666.5.896"
    }
  ],
  "version" : "20160331",
  "name" : "IVAntipseudomonalQuinolones",
  "title" : "IV Antipseudomonal quinolones",
  "status" : "retired",
  "experimental" : false,
  "date" : "2016-03-31T01:00:12-04:00",
  "publisher" : "Lantana EH Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This set of values contains medications that are commonly used in an inpatient setting for pneumonia. These medications include intravenous  (IV) Antipseudomonal quinolones that are either specifically mentioned in clinical practice guidelines or are reasonable therapeutic equivalents.),(Data Element Scope: The intent of this data element is to identify patients who are on active medication therapy. Using the Quality Data Model, this particular element will map to the \"Medication\" category.),(Inclusion Criteria: Include quinolone drugs which are given in the case of an infection caused by pseudomonas by intravenous route.),(Exclusion Criteria: The drug concepts should be limited to those which are appropriate for human use and available to be prescribed in the United States.  Drugs that take on oral, topical or suppository forms should not be included.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1665210",
            "display" : "100 ML Ciprofloxacin 2 MG/ML Injection"
          },
          {
            "code" : "1665212",
            "display" : "200 ML Ciprofloxacin 2 MG/ML Injection"
          },
          {
            "code" : "1665227",
            "display" : "20 ML Ciprofloxacin 10 MG/ML Injection"
          },
          {
            "code" : "1665229",
            "display" : "40 ML Ciprofloxacin 10 MG/ML Injection"
          },
          {
            "code" : "1665497",
            "display" : "50 ML Levofloxacin 5 MG/ML Injection"
          },
          {
            "code" : "1665507",
            "display" : "100 ML Levofloxacin 5 MG/ML Injection"
          },
          {
            "code" : "1665515",
            "display" : "150 ML Levofloxacin 5 MG/ML Injection"
          },
          {
            "code" : "1665517",
            "display" : "20 ML Levofloxacin 25 MG/ML Injection"
          },
          {
            "code" : "1665519",
            "display" : "30 ML Levofloxacin 25 MG/ML Injection"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:89962afe-5aac-4346-93d3-4a0f7a85f8db",
    "timestamp" : "2024-06-14T18:04:02-04:00",
    "total" : 8,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665210",
        "display" : "100 ML ciprofloxacin 2 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665212",
        "display" : "200 ML ciprofloxacin 2 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665229",
        "display" : "40 ML ciprofloxacin 10 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665497",
        "display" : "50 ML levofloxacin 5 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665507",
        "display" : "100 ML levofloxacin 5 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665515",
        "display" : "150 ML levofloxacin 5 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665517",
        "display" : "20 ML levofloxacin 25 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1665519",
        "display" : "30 ML levofloxacin 25 MG/ML Injection"
      }
    ]
  }
}
